Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2006) | Total Docs. (3years) | Total Refs. (2006) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2006) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Nature Reviews Drug Discovery | journal | 7.332 Q1 | 391 | 162 | 916 | 7271 | 5779 | 265 | 5.58 | 44.88 |  |
| 2 | Reviews of Physiology Biochemistry and Pharmacology | journal | 6.223 Q1 | 70 | 8 | 44 | 1340 | 537 | 44 | 8.71 | 167.50 |  |
| 3 | Trends in Pharmacological Sciences | journal | 4.402 Q1 | 244 | 104 | 356 | 5460 | 3669 | 324 | 10.55 | 52.50 | |
| 4 | Cellular and Molecular Life Sciences | journal | 2.857 Q1 | 261 | 258 | 782 | 24555 | 4185 | 776 | 5.10 | 95.17 |  |
| 5 | Current Opinion in Pharmacology | journal | 2.803 Q1 | 148 | 98 | 308 | 4299 | 2098 | 279 | 7.45 | 43.87 |  |
| 6 | Neuropsychopharmacology | journal | 2.724 Q1 | 249 | 285 | 762 | 16343 | 4804 | 734 | 6.33 | 57.34 | |
| 7 | Neurotherapeutics | journal | 1.932 Q1 | 136 | 53 | 109 | 4821 | 655 | 98 | 6.01 | 90.96 | |
| 8 | Neuropharmacology | journal | 1.921 Q1 | 191 | 229 | 730 | 10800 | 3166 | 727 | 4.37 | 47.16 | |
| 9 | Psychopharmacology | journal | 1.892 Q1 | 214 | 366 | 1156 | 19456 | 5043 | 1107 | 4.18 | 53.16 | |
| 10 | Drug and Alcohol Dependence | journal | 1.854 Q1 | 187 | 210 | 463 | 8779 | 1946 | 452 | 3.93 | 41.80 |  |
| 11 | Current Drug Metabolism | journal | 1.835 Q1 | 122 | 65 | 123 | 7593 | 861 | 117 | 6.92 | 116.82 | |
| 12 | Cancer Chemotherapy and Pharmacology, Supplement | journal | 1.826 Q1 | 35 | 0 | 14 | 0 | 57 | 14 | 0.00 | 0.00 | |
| 13 | Antiviral Therapy | journal | 1.790 Q1 | 93 | 126 | 326 | 4438 | 1413 | 312 | 4.46 | 35.22 | |
| 14 | International Journal of Neuropsychopharmacology | journal | 1.777 Q1 | 125 | 95 | 201 | 3483 | 855 | 169 | 4.22 | 36.66 | |
| 15 | Journal of Antimicrobial Chemotherapy | journal | 1.771 Q1 | 221 | 485 | 1381 | 11635 | 5642 | 1169 | 4.07 | 23.99 | |
| 16 | Apoptosis : an international journal on programmed cell death | journal | 1.761 Q1 | 128 | 192 | 283 | 9438 | 1189 | 281 | 3.73 | 49.16 | |
| 17 | Controlled Clinical Trials | journal | 1.648 Q1 | 76 | 0 | 117 | 0 | 406 | 106 | 4.30 | 0.00 | |
| 18 | Clinical Pharmacokinetics | journal | 1.534 Q1 | 184 | 82 | 241 | 5255 | 1530 | 238 | 5.41 | 64.09 | |
| 19 | Current Opinion in Drug Discovery and Development | journal | 1.404 Q1 | 85 | 67 | 245 | 3875 | 1246 | 229 | 5.43 | 57.84 | |
| 20 | European Neuropsychopharmacology | journal | 1.382 Q1 | 130 | 91 | 258 | 4338 | 995 | 256 | 4.03 | 47.67 | |
| 21 | Pharmacogenomics Journal | journal | 1.357 Q1 | 95 | 54 | 158 | 2304 | 673 | 139 | 4.74 | 42.67 | |
| 22 | Drug Safety | journal | 1.352 Q1 | 140 | 93 | 262 | 5283 | 1202 | 245 | 4.54 | 56.81 | |
| 23 | American Journal of Respiratory Medicine | journal | 1.279 Q1 | 34 | 0 | 42 | 0 | 173 | 42 | 0.00 | 0.00 | |
| 24 | Expert Opinion on Therapeutic Targets | journal | 1.268 Q1 | 106 | 84 | 204 | 7122 | 651 | 195 | 3.07 | 84.79 | |
| 25 | Drug Discovery Today | journal | 1.251 Q1 | 215 | 161 | 1060 | 7603 | 3278 | 847 | 3.22 | 47.22 | |
| 26 | Current Drug Targets: Inflammation and Allergy | journal | 1.209 Q1 | 53 | 0 | 172 | 0 | 620 | 159 | 3.62 | 0.00 | |
| 27 | Journal of Psychopharmacology | journal | 1.183 Q1 | 135 | 144 | 275 | 6477 | 851 | 238 | 3.09 | 44.98 | |
| 28 | Receptors and Channels | journal | 1.143 Q1 | 44 | 0 | 59 | 0 | 169 | 56 | 2.53 | 0.00 | |
| 29 | Antiviral Research | journal | 1.139 Q1 | 151 | 118 | 262 | 5565 | 980 | 260 | 3.40 | 47.16 | |
| 30 | Current Opinion in Investigational Drugs | journal | 1.120 Q1 | 83 | 132 | 484 | 7673 | 1527 | 446 | 3.01 | 58.13 | |
| 31 | Expert Opinion on Investigational Drugs | journal | 1.075 Q1 | 117 | 138 | 426 | 11102 | 1507 | 414 | 3.45 | 80.45 | |
| 32 | Investigational New Drugs | journal | 1.068 Q1 | 97 | 64 | 165 | 2161 | 577 | 162 | 3.27 | 33.77 | |
| 33 | European Journal of Pharmacology | journal | 1.060 Q1 | 203 | 754 | 2151 | 30523 | 6429 | 2141 | 2.86 | 40.48 | |
| 34 | American Journal of PharmacoGenomics | journal | 0.965 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 35 | Pharmacogenomics | journal | 0.939 Q2 | 100 | 115 | 282 | 4762 | 853 | 244 | 3.40 | 41.41 | |
| 36 | Journal of Ethnopharmacology | journal | 0.924 Q2 | 231 | 407 | 1042 | 12847 | 2637 | 1033 | 2.27 | 31.57 | |
| 37 | Expert Opinion on Biological Therapy | journal | 0.910 Q2 | 102 | 118 | 426 | 10116 | 1358 | 420 | 3.26 | 85.73 | |
| 38 | Current Opinion in Molecular Therapeutics | journal | 0.908 Q2 | 67 | 69 | 270 | 3935 | 701 | 241 | 2.55 | 57.03 | |
| 39 | PharmacoEconomics | journal | 0.898 Q2 | 118 | 137 | 334 | 5024 | 938 | 307 | 2.56 | 36.67 | |
| 40 | Planta Medica | journal | 0.896 Q2 | 135 | 260 | 769 | 5554 | 1740 | 761 | 2.04 | 21.36 | |
| 41 | British Journal of Clinical Pharmacology | journal | 0.879 Q2 | 167 | 207 | 632 | 5596 | 1889 | 534 | 2.93 | 27.03 | |
| 42 | Cancer Chemotherapy and Pharmacology | journal | 0.858 Q2 | 122 | 222 | 488 | 6029 | 1385 | 488 | 2.89 | 27.16 | |
| 43 | Progress in Medicinal Chemistry | journal | 0.849 Q2 | 38 | 8 | 23 | 1253 | 67 | 20 | 2.60 | 156.63 | |
| 44 | Expert Review of Vaccines | journal | 0.810 Q2 | 105 | 76 | 265 | 6009 | 679 | 243 | 2.24 | 79.07 | |
| 45 | BioDrugs | journal | 0.786 Q2 | 79 | 42 | 125 | 2488 | 383 | 123 | 3.70 | 59.24 | |
| 46 | Journal of Peptide Science | journal | 0.775 Q2 | 73 | 110 | 248 | 3484 | 494 | 239 | 1.84 | 31.67 | |
| 47 | International Immunopharmacology | journal | 0.768 Q2 | 149 | 243 | 551 | 8584 | 1363 | 547 | 2.41 | 35.33 | |
| 48 | Naunyn-Schmiedeberg's Archives of Pharmacology | journal | 0.767 Q2 | 99 | 94 | 386 | 4860 | 1009 | 382 | 3.03 | 51.70 | |
| 49 | Phytomedicine | journal | 0.758 Q2 | 141 | 129 | 326 | 3506 | 758 | 317 | 2.02 | 27.18 | |
| 50 | Cardiovascular Drugs and Therapy | journal | 0.756 Q2 | 79 | 56 | 186 | 2148 | 330 | 159 | 1.47 | 38.36 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data